# Amit Mehta

> Amit Mehta is a seed investor at Builders VC backing Coffee, Health Care and Therapeutics. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Builders VC](https://shizune.co/investors/profile/builders)
- Total investments: 2
- Last investment: Sep 2022
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/dramehta/
- X (Twitter): https://twitter.com/dramehta
- Website: https://www.builders.vc

Amit Mehta is a seed investor at Builders VC focused on Coffee and Health Care. Dr. Amit Mehta leads our health-IT investment practice. As a highly-regarded practicing professional, Amit combines practical knowledge across the value-chain with entrepreneurial experience to help companies from seed through Series B. Amit manages our investments into Carbon Health, Notable Labs and Fitbiomics, in addition to driving our overallHealth IT strategy. Prior to Builders, he was instrumental in deploying investments for Formation 8 in the health sector. His primary interest focusses on helping Builders' founders in market fit and establishing partnerships with hospital systems, clinics and ICNs. He is deeply interested in market validation of new technologies as well as successful strategies in go-to-market launches. Dr. Mehta completed his residency in Diagnostic Radiology at Harvard Medical School where he also completed a fellowship in Minimally Invasive Image Guided Surgery. He is a founder and the Chief Medical Officer at Intrinsic Imaging, a leading Healthcare IT company operating clinical trials in 64 countries globally for both pharma and biotech sponsors. He has co-authored three textbooks in Radiology, has widely published in peer-reviewed journals and currently is appointed as an SBIR/STTR reviewer for the National Institutes of Health. In addition to his clinical and operational pursuits, Amit serves on the boards of various start-ups and enjoys assisting entrepreneurs in launching early stage companies. He has been selected as one of the “Top 40 under 40″ by the San Antonio Business Journal.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Coffee | 1 | 50% |
| Health Care | 1 | 50% |
| Therapeutics | 1 | 50% |
| Biotechnology | 1 | 50% |
| Pharmaceutical | 1 | 50% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Series A | 1 | 50% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| India | 1 | 50% |
| United States | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Arpeggio Bio | Arpeggio Biosciences leverages state of the art sequencing approaches coupled with powerful machine learning to uncover novel insights into a compound's biological mechanism of action.The company is diverse set of molecular biologists, computer scientists, and biotechnology enthusiasts passionate about understanding where, why, and howtherapeutics work. | $17M | Series A | Sep 07, 2022 |  |
| The Betel Leaf Co. | The Betel Leaf Co. is India’s first FSSAI Approved Online Paan delivery company. It's aim is to redefine the age-old tradition of the great Indian Dessert- Paan. With 45 different Flavours, its Paan & Betel Bars make for a perfect post- meal craving solution. | $800K | Seed | Nov 30, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [100Unicorns](https://shizune.co/investors/profile/9unicorns) — VC Fund, 1 deal together
- [Fifty Years](https://shizune.co/investors/profile/fifty-years) — VC Fund, 1 deal together
- [Formic Ventures](https://shizune.co/investors/profile/formic-ventures) — VC Fund, 1 deal together
- [FundersClub](https://shizune.co/investors/profile/fundersclub) — VC Fund, 1 deal together
- [Khosla Ventures](https://shizune.co/investors/profile/khosla-ventures) — VC Fund, 1 deal together
- [Tau Ventures](https://shizune.co/investors/profile/tau-ventures-e0e2) — VC Fund, 1 deal together

## About Builders VC

VC Fund · San Francisco, United States

Builders VC is an early-stage venture capital firm focused on investing where technology meets new business models to modernize antiquated industries including healthcare, agriculture, industrials and real-estate.

5 contacts available at Builders VC.

| Name | Title | Profile |
| --- | --- | --- |
| Amit Mehta | General Partner | https://shizune.co/investors/profile/amit-mehta-5e2d |
| Jim Kim | Founder & General Partner | https://shizune.co/investors/profile/jim-kim |
| Mark Goldstein | Partner | https://shizune.co/investors/profile/mark-goldstein |
| Alex Kinnier | Partner | https://shizune.co/investors/profile/alex-kinnier |
| Jocelyn Doe | General Partner | https://shizune.co/investors/profile/jocelyn-doe-5655 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Amit Mehta invest in?

Amit Mehta invests primarily in Coffee, Health Care and Therapeutics startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Amit Mehta last invest?

The most recent investment recorded for Amit Mehta closed in Sep 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co